What is a stock summary page? Click here for an overview.
Business Description
BioHarvest Sciences Inc
NAICS : 311999
SIC : 1099
ISIN : CA09076J1084
Compare
Compare
Traded in other countries / regions
BHST.USABHSC.Canada8MV0.Germany IPO Date
2020-12-10Description
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.26 | |||||
| Equity-to-Asset | 0.16 | |||||
| Debt-to-Equity | 2.58 | |||||
| Debt-to-EBITDA | -1.27 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.37 | |||||
| Beneish M-Score | -3.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 183.7 | |||||
| 3-Year EBITDA Growth Rate | -6.7 | |||||
| 3-Year EPS without NRI Growth Rate | -13.2 | |||||
| 3-Year FCF Growth Rate | -21 | |||||
| 3-Year Book Growth Rate | -77 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 65.99 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.09 | |||||
| 9-Day RSI | 46.12 | |||||
| 14-Day RSI | 46.42 | |||||
| 3-1 Month Momentum % | -2.79 | |||||
| 6-1 Month Momentum % | 15.68 | |||||
| 12-1 Month Momentum % | 6.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | |||||
| Quick Ratio | 0.48 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 91.78 | |||||
| Days Sales Outstanding | 13.88 | |||||
| Days Payable | 100.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.2 | |||||
| Shareholder Yield % | -2.61 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54 | |||||
| Operating Margin % | -35 | |||||
| Net Margin % | -76.65 | |||||
| FCF Margin % | -44.72 | |||||
| ROA % | -94.1 | |||||
| ROIC % | -40.8 | |||||
| 3-Year ROIIC % | -15 | |||||
| ROC (Joel Greenblatt) % | -92.88 | |||||
| ROCE % | -264.25 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 37.16 | |||||
| PS Ratio | 4.5 | |||||
| PB Ratio | 27.43 | |||||
| Price-to-Tangible-Book | 27.75 | |||||
| EV-to-EBIT | -12.7 | |||||
| EV-to-Forward-EBIT | -17.03 | |||||
| EV-to-EBITDA | -14.4 | |||||
| EV-to-Forward-EBITDA | -23.82 | |||||
| EV-to-Revenue | 5.42 | |||||
| EV-to-Forward-Revenue | 2.53 | |||||
| EV-to-FCF | -12.12 | |||||
| Price-to-GF-Value | 0.39 | |||||
| Earnings Yield (Greenblatt) % | -7.87 | |||||
| FCF Yield % | -8.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioHarvest Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 20.552 | ||
| EPS (TTM) (€) | -1.217 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.2 | ||
| 3-Year Sortino Ratio | -0.29 | ||
| Volatility % | 47.47 | ||
| 14-Day RSI | 46.42 | ||
| 14-Day ATR (€) | 0.20654 | ||
| 20-Day SMA (€) | 4.98025 | ||
| 12-1 Month Momentum % | 6.1 | ||
| 52-Week Range (€) | 4.095 - 6.824999 | ||
| Shares Outstanding (Mil) | 17.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioHarvest Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioHarvest Sciences Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioHarvest Sciences Inc Frequently Asked Questions
What is BioHarvest Sciences Inc(STU:8MV0)'s stock price today?
The current price of STU:8MV0 is €5.00. The 52 week high of STU:8MV0 is €6.82 and 52 week low is €4.10.
When is next earnings date of BioHarvest Sciences Inc(STU:8MV0)?
The next earnings date of BioHarvest Sciences Inc(STU:8MV0) is 2025-03-31.
Does BioHarvest Sciences Inc(STU:8MV0) pay dividends? If so, how much?
BioHarvest Sciences Inc(STU:8MV0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers